Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/95997
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWardill, H.-
dc.contributor.authorVan Sebille, Y.-
dc.contributor.authorMander, K.-
dc.contributor.authorGibson, R.-
dc.contributor.authorLogan, R.-
dc.contributor.authorBowen, J.-
dc.contributor.authorSonis, S.-
dc.date.issued2015-
dc.identifier.citationCancer Treatment Reviews, 2015; 41(2):122-128-
dc.identifier.issn0305-7372-
dc.identifier.issn1532-1967-
dc.identifier.urihttp://hdl.handle.net/2440/95997-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityHannah R. Wardill, Ysabella Z.A. Van Sebille, Kimberley A. Mander, Rachel J. Gibson, Richard M. Logan, Joanne M. Bowen, Stephen T. Sonis-
dc.language.isoen-
dc.publisherElsevier-
dc.rights© 2014 Elsevier Ltd. All rights reserved.-
dc.source.urihttp://dx.doi.org/10.1016/j.ctrv.2014.11.005-
dc.subjectChemotherapy-
dc.subjectNeurotoxicity-
dc.subjectNeuropathy-
dc.subjectGut toxicity-
dc.subjectToll-Like Receptor 4-
dc.subjectGlial activation-
dc.titleToll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities an emerging hypothesis for neuropathy and gastrointestinal toxicity-
dc.typeJournal article-
dc.identifier.doi10.1016/j.ctrv.2014.11.005-
pubs.publication-statusPublished-
dc.identifier.orcidWardill, H. [0000-0002-6613-3661]-
dc.identifier.orcidGibson, R. [0000-0002-4796-1621]-
dc.identifier.orcidLogan, R. [0000-0002-9331-1814]-
dc.identifier.orcidBowen, J. [0000-0003-0876-0031]-
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.